Opinion
Video
Standardizing CRS Management and Ensuring Smooth Transitions of Care in Bispecific Therapy
Experts discuss why it is critical to have standardized protocols in place for managing cytokine release syndrome (CRS) in patients receiving bispecific antibodies, outlining the key components of an effective CRS management protocol as well as best practices for transitions of care between settings when administering and managing bispecifics.
Video content above is prompted by the following:
- Why is it critical to have standardized protocols in place for managing CRS in patients receiving bispecific antibodies?
- What are the key components of an effective CRS management protocol?
- What are best practices for transitions of care between settings when administering and managing bispecifics?
Related Videos
Related Content
